Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
申请人:Cai Shaopei
公开号:US20050209247A1
公开(公告)日:2005-09-22
A lacate salt of a compound of Formula I or a tautomer of the compound, wherein Formula I has the following structure and R
1
-R
9
and R
12
-R
14
are as defined herein
PHARMACEUTICALLY ACCEPTABLE SALTS OF QUINOLINONE COMPOUNDS HAVING IMPROVED PHARMACEUTICAL PROPERTIES
申请人:Cai Shaopei
公开号:US20130018058A1
公开(公告)日:2013-01-17
A lacate salt of a compound of Formula I or a tautomer of the compound, wherein Formula I has the following structure and R
1
-R
9
and R
12
-R
14
are as defined herein
Pharmaceutically Acceptable Salts of Quinolinone Compounds Having Improved Pharmaceutical Properties
申请人:Cai Shaopei
公开号:US20130338171A1
公开(公告)日:2013-12-19
A lacate salt of a compound of Formula I or a tautomer of the compound, wherein Formula I has the following structure and R
1
-R
9
and R
12
-R
14
are as defined herein
Pharmaceutically acceptable salts of quinolinone compounds and their medical use
申请人:Novartis Vaccines and Diagnostics, Inc.
公开号:EP2762475A1
公开(公告)日:2014-08-06
A salt of a compound of Formula I or a tautomer of the compound, wherein Formula I has the following structure and R1-R9 and R12-R14 are as defined herein
式 I 化合物的盐或该化合物的同系物,其中式 I 具有如下结构,R1-R9 和 R12-R14 如本文所定义